Description
Lenvatinib is a prescription medication used to treat certain types of cancer. It belongs to a class of medications known as tyrosine kinase inhibitors, which work by blocking the growth and spread of cancer cells. Lenvatinib is specifically designed to target and inhibit the activity of certain enzymes involved in cancer cell growth and angiogenesis, the formation of new blood vessels that supply the tumor with nutrients.
Indications / Uses
Lenvatinib is commonly prescribed for:
- Renal Cell Carcinoma: a type of kidney cancer that originates in the lining of the proximal convoluted tubule, a part of the small tubes in the kidney that transport waste molecules from the blood to the urine.
- Thyroid Cancer: a type of cancer that affects the thyroid gland, which is a butterfly-shaped gland located in the neck, responsible for producing hormones that regulate metabolism.
Key Features
- Highly selective inhibitor of multiple receptor tyrosine kinases, including VEGFR, FGFR, and PDGFR.
- Oral administration, once daily, with or without food.
- Available in , allowing for flexible dosing and adjustment based on individual patient needs.
Storage
Lenvatinib should be stored at room temperature, away from moisture and light. The capsules should be kept in their original packaging and protected from extreme temperatures. It is essential to follow the storage instructions provided by the manufacturer or pharmacist to ensure the quality and efficacy of the medication.
Important Note
Lenvatinib may cause serious side effects, including hypertension, diarrhea, fatigue, and proteinuria. Patients should be closely monitored for signs of adverse reactions and should report any unusual symptoms to their healthcare provider. It is essential to take Lenvatinib exactly as prescribed and to follow the recommended dosage and administration instructions to minimize the risk of side effects. Women who are pregnant or breastfeeding should not take Lenvatinib , as it may harm the fetus or baby.
Reviews
There are no reviews yet.